These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5483974)

  • 61. Coagulation for cardiologists.
    Wessler S; Gitel SN
    Am Heart J; 1978 Dec; 96(6):811-23. PubMed ID: 362880
    [No Abstract]   [Full Text] [Related]  

  • 62. [The antithrombotic and thrombolytic activity of tuftsin].
    Liapina LA; Pastorova VE; Kondashevskaia MV; Kudriashov BA; Kalikhevich VN; Kamenskiĭ AA; Ashmarin IP
    Biull Eksp Biol Med; 1993 Nov; 116(11):451-2. PubMed ID: 8312523
    [No Abstract]   [Full Text] [Related]  

  • 63. [Effects of products obtained by enzymatic splitting of bacterial proteins on the blood fibrinolytic system of the dog].
    Tomuş L; Suciu A; Rusu M; Cordoş D
    Fiziol Norm Patol; 1971; 17(1):11-20. PubMed ID: 5554045
    [No Abstract]   [Full Text] [Related]  

  • 64. [Influence of various factors on tissue fibrinolysis].
    Donner L; Houskova J
    Nouv Rev Fr Hematol; 1968; 8(2):251-4. PubMed ID: 4232371
    [No Abstract]   [Full Text] [Related]  

  • 65. Experimental studies on the anticoagulant and antithrombotic effects of sodium and calcium pentosan polysulphate.
    Giedrojć J; Radziwon P; Klimiuk M; Bielawiec M; Breddin HK; Kłoczko J
    J Physiol Pharmacol; 1999 Mar; 50(1):111-9. PubMed ID: 10210159
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tissue factor pathway inhibitor: a potent inhibitor of in-vitro coagulation and in-vivo thrombus formation.
    Lindahl AK
    Curr Opin Lipidol; 1994 Dec; 5(6):434-9. PubMed ID: 7712048
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).
    Xiong J; Fang W; Fang W; Bai L; Huo J; Kong Y; Yunman L
    J Pharm Pharmacol; 2009 Jan; 61(1):89-94. PubMed ID: 19126301
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mechanism of action and thrombolytic potential of staphylokinase.
    Lijnen HR
    Verh K Acad Geneeskd Belg; 1995; 57(4):303-14. PubMed ID: 8571666
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Study of a glycoprotein from Gastrodia elata: its effects of anticoagulation and antithrombosis].
    Ding CS; Shen YS; Li G; Wei Z; Wei F
    Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(11):1060-4. PubMed ID: 17672344
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Fibrinolytic action of Complamin (R). Preliminary report].
    Harel P; Gauthier J
    Union Med Can; 1966 May; 95(5):542-5. PubMed ID: 5932651
    [No Abstract]   [Full Text] [Related]  

  • 75. [Morphological and histochemical studies of connective tissue in a transplantable Guerin epithelioma following cysteine administration].
    Borejszo IT
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1982; 27():3-20. PubMed ID: 6306754
    [No Abstract]   [Full Text] [Related]  

  • 76. Effect of nicotinic acid on fibrinolytic activity in health, in thrombotic disease and in liver cirrhosis.
    Robertson BR
    Acta Chir Scand; 1971; 137(7):643-8. PubMed ID: 5149150
    [No Abstract]   [Full Text] [Related]  

  • 77. [Effect of tricholysine on plasma fibrinolytic activity].
    Serebriakova TN; Andreenko GV; Maksimova RA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1981; (8):46-51. PubMed ID: 7196773
    [No Abstract]   [Full Text] [Related]  

  • 78. Thrombolytic effect of urokinase on artificial thrombi in vitro.
    Suyama T; Odashima S; Iga Y; Shibuya Y
    Kobe J Med Sci; 1969 Sep; 15(3):137-47. PubMed ID: 5367403
    [No Abstract]   [Full Text] [Related]  

  • 79. Construction and functional evaluation of hirudin derivatives with low bleeding risk.
    Zhang C; Yu A; Yuan B; Dong C; Yu H; Wang L; Wu C
    Thromb Haemost; 2008 Feb; 99(2):324-30. PubMed ID: 18278181
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Experimental study of the distribution of terrilytin-125I in the body].
    Andreev SV; Kasatkin IuN; Kubatiev AA; Iurkiv VA; Masenko VP
    Dokl Akad Nauk SSSR; 1975 Jul; 223(3):748-50. PubMed ID: 1192940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.